ClinConnect ClinConnect Logo
Search / Trial NCT06287255

Feasibility and Acceptability of Incorporating Smartwatches Into an Exercise is Medicine Program in Older Individuals

Launched by OHIO STATE UNIVERSITY · Feb 28, 2024

Trial Information

Current as of August 20, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at how using smartwatches can help older adults, aged 65 and above, become more active as part of a program called Exercise is Medicine. We know that regular exercise can help prevent serious health issues, like heart disease and diabetes, and improve overall quality of life. By providing smartwatches to participants, the goal is to encourage them to move more and stay healthier.

To join this study, participants need to be at least 65 years old, speak English, and not have any major health restrictions that would prevent them from exercising. This means they shouldn't have serious heart problems or other significant health issues. If eligible, participants will receive a smartwatch and be part of a program that promotes physical activity tailored for their needs. This trial is an exciting opportunity to see if technology can make it easier for older adults to stay active and improve their health.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age 65+
  • No healthcare provider-imposed limitations on physical activity
  • English-speaking
  • Exclusion Criteria:
  • Symptoms suggestive of coronary artery disease (CAD) or congestive heart failure (CHF) (i.e. chest pain, dizziness, syncope, excessive dyspnea on exertion)
  • Myocardial infarction within the last 12 months
  • Revascularization within the last 12 months
  • Stroke/transient ischemic attack (TIA) within the past 12 months
  • Unstable angina
  • Congestive heart failure (New York Heart Association (NYHA) Class II, III or IV)
  • Ventricular arrhythmia
  • Clinically significant cardiac valve disease
  • Blood pressure \>160/100 mmHg
  • Uncontrolled seizure disorder
  • Major surgery within the past three months
  • Severe or frequent hypoglycemia
  • Inability to independently manage blood glucose during activity
  • Severe autonomic or peripheral neuropathy
  • Active foot ulcers
  • Unstable retinopathy.

About Ohio State University

The Ohio State University (OSU) is a leading research institution dedicated to advancing health and science through innovative clinical trials. With a commitment to improving patient care and outcomes, OSU leverages its extensive resources, interdisciplinary collaboration, and expertise in diverse medical fields. The university fosters an environment of rigorous scientific inquiry, ensuring that clinical trials are conducted with the highest ethical standards and adherence to regulatory guidelines. Through its Clinical Trials Office, OSU aims to translate groundbreaking research into practical applications, benefiting both local and global communities.

Locations

Columbus, Ohio, United States

Columbus, Ohio, United States

Patients applied

0 patients applied

Trial Officials

Joshua Joseph, MD

Principal Investigator

Ohio State University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported